Last Updated: March 18, 2026
Ketamine Side Effects: What to Know Before Treatment
Ketamine therapy can raise understandable questions about what to expect physically and mentally — both during sessions and over time. This article covers the most common side effects, serious risks that warrant immediate attention, long-term considerations associated with unsupervised use, and how clinician-supervised protocols are designed to keep treatment safe.
Key takeaways
- In a peer-reviewed study of 11,441 patients treated under the Mindbloom clinical protocol, serious adverse events occurred in fewer than 0.1% of sessions.
- Side effects during clinician-supervised ketamine therapy are typically temporary, with approximately 4-5% of sessions reporting side effects like nausea or dizziness.
- Long-term risks such as bladder damage and cognitive impairment are primarily documented in patterns of chronic, high-dose, unsupervised recreational use.
- Combining ketamine with central nervous system depressants like alcohol or opioids significantly increases the risk of respiratory depression and overdose.
Common Ketamine Side Effects During Clinician-Supervised Treatment
The most frequently reported side effects during therapeutic ketamine sessions include dissociation, nausea, dizziness, fatigue, headache, temporary blood pressure changes, and anxiety. Some people experience these effects, but they are not guaranteed outcomes for everyone.
When side effects do occur, they are generally well-understood pharmacological responses to the medication. These common physical and perceptual shifts are typically time-limited, resolving within a few hours of the session ending.
Clinician-supervised programs use preparation materials, a required peer treatment monitor, and carefully selected dosing to help you navigate the experience safely.
Dissociation and Perceptual Changes
Dissociation is a temporary shift in how you perceive your body, your surroundings, or your sense of self. In the context of ketamine therapy, this is a known pharmacological effect rather than a medical complication.
Many people describe this dissociative state as meaningful or even positive within a defined treatment framework. However, it can feel unfamiliar or intense for some, particularly during early sessions.
This occurs because ketamine temporarily modulates NMDA receptors in the brain, adjusting signaling between different neural networks.1 Preparation materials and the presence of a peer treatment monitor help people navigate this perceptual shift.
Clinicians position dissociation as a core part of the therapeutic process, not something to fear or suppress.
Nausea and Vomiting
Nausea and vomiting are among the most commonly reported physical side effects of ketamine across all routes of administration. Some people experience mild stomach upset, while others may feel more significant nausea.
Ketamine can stimulate the vestibular system, which controls balance, and affect central nausea pathways in the brain. When it does occur, nausea typically subsides within a few hours and often diminishes naturally with subsequent sessions.
To manage this, clinicians often recommend specific fasting guidelines before sessions. They may also prescribe anti-nausea medication (antiemetics) as part of your personalized treatment protocol.
Dizziness and Unsteady Coordination
Dizziness, lightheadedness, and impaired motor coordination are common during and shortly after a ketamine session. Some people experience a temporary loss of balance or spatial orientation.
Ketamine temporarily affects cerebellar function and proprioception, which are responsible for physical coordination. This is why treatment protocols require sessions to take place in a reclined, stationary position in a safe environment.
Your required peer treatment monitor is present throughout the session to ensure your physical safety if you need to move, such as going to the restroom. Because coordination remains impaired after the immediate effects fade, driving and operating machinery must be avoided until after a full night of sleep.
Fatigue and Drowsiness
Post-session fatigue and drowsiness are commonly reported as the medication wears off. Some people feel a lingering sense of tiredness that lasts for the remainder of the day.
Sedation is a known pharmacological property of ketamine at therapeutic doses. During the post-session period, some people feel ready to resume non-driving activities later the same day, while others prefer to keep their schedule clear to rest.
Individual response varies significantly. You should discuss post-session timing and expectations with your clinician to find a rhythm that works best for your body.
Headache
Mild headaches may occur during or after a ketamine session for some individuals. These are typically transient and resolve on their own.
Headaches can be related to mild changes in blood flow, unconscious muscle tension during the session, or simply your hydration status.
Maintaining proper hydration before and after sessions, along with resting during the post-session transition, can help prevent or alleviate this effect. Persistent or severe headaches should always be reported to your clinician.
Temporary Blood Pressure Increase
Some people experience a modest, transient increase in blood pressure and heart rate during their session. This is a known cardiovascular effect of the medication.
Ketamine has sympathomimetic properties, meaning it temporarily stimulates the cardiovascular system.2 While this mild elevation is generally well-tolerated by healthy individuals, those with uncontrolled hypertension may not be appropriate candidates for treatment.
This is exactly why comprehensive cardiovascular screening is a mandatory part of the clinical intake process. Your clinician will evaluate your blood pressure history and cardiac health before determining if treatment is medically appropriate.
Anxiety or Agitation Symptoms During Sessions
While relatively rare, some people may experience heightened anxiety or agitation-like symptoms during a session. This is more commonly reported during early sessions when the experience is entirely new.
The altered state of consciousness can temporarily amplify pre-existing anxiety in some individuals if they feel a loss of control. It is important to note that this temporary in-session anxiety is distinct from a worsening of your underlying mental health condition.
Preparation materials provide specific breathing techniques to use if this occurs, and your peer treatment monitor is there to offer grounding support. If anxiety is persistent across multiple sessions, clinicians will adjust your treatment plan accordingly.
Serious Ketamine Side Effects and When to Seek Urgent Care
Serious adverse events are rare in clinician-supervised therapeutic settings, but they require immediate medical attention if they occur. It is important to distinguish these rare medical emergencies from the transient effects expected during a normal session.
Protocol-driven clinical programs are designed to minimize these risks through rigorous medical screening, eligibility assessments, and strict session rules. If any of the following serious effects occur, you should contact your clinician immediately or seek emergency medical care.
- Breathing problems: Dangerously slowed or shallow breathing.
- Dangerous blood pressure spikes: Severe hypertension or sudden chest pain.
- Allergic reactions: Facial swelling, hives, or restricted airways.
- Severe bladder pain: Acute urinary distress or visible blood in the urine.
Breathing Problems and Extreme Sedation
Respiratory depression—dangerously slowed or shallow breathing—is the most clinically significant acute risk associated with ketamine.
This risk increases substantially when ketamine is combined with other central nervous system (CNS) depressants, such as alcohol, benzodiazepines, or opioids.3 Within a clinician-supervised protocol that includes medication screening, avoidance of sedative co-use, and session monitoring, respiratory depression is uncommon.
Medication screening, substance-use assessments, and the required peer treatment monitor exist specifically to guard against this risk. The monitor is trained to observe your breathing and seek emergency help if it becomes dangerously slow.
Chest Pain and Dangerous Blood Pressure Spikes
While mild blood pressure increases are common, clinically significant cardiovascular events are a serious risk that requires immediate attention.
A dangerous spike in blood pressure or sustained rapid heartbeat is fundamentally different from a modest temporary increase. Individuals with pre-existing cardiovascular conditions are at a higher risk for these events, which is why thorough screening is required.
Chest pain, a pounding heart that does not subside, or blood pressure readings significantly above your baseline during or after a session warrant immediate emergency medical attention.
Allergic Reactions and Facial Swelling
Allergic reactions to ketamine—including rash, hives, swelling of the face, lips, or throat, and difficulty breathing—are rare but require an immediate emergency response.
True anaphylaxis to ketamine is extremely rare in the medical literature, but it is documented.4 Any signs of an allergic reaction during or after a session should be treated as a medical emergency.
If you or your monitor observe facial swelling or restricted airways, call 911 or go to the nearest emergency room immediately. You must also report the reaction to your prescribing clinician.
Severe Bladder Pain or Blood in Urine
Ketamine-associated bladder symptoms, such as severe pain, urgency, frequency, or blood in the urine, are known risks. However, these are primarily associated with chronic, high-dose, unsupervised recreational use.
Ketamine cystitis involves direct irritation of the bladder lining by the medication and its metabolites.5 In therapeutic programs with defined treatment courses, clinical screening, and ongoing monitoring, this acute presentation is uncommon.
Despite the lower risk in clinical settings, any new urinary symptoms should be reported promptly. Clinicians monitor for emerging symptoms across the treatment course to allow for timely intervention if needed.
Ketamine Overdose Risk
A ketamine overdose is a severe medical emergency characterized by unconsciousness, severely depressed breathing, convulsions, and potential cardiovascular collapse. It requires immediate, life-saving medical intervention.
Overdose risk is primarily associated with unsupervised use, recreational doses that far exceed therapeutic ranges, and the concurrent use of other CNS depressants like alcohol or opioids.6 At clinician-determined therapeutic doses within a clinically managed protocol, overdose is extremely unlikely.
Clinician-supervised programs mitigate overdose risk through precise prescription controls, comprehensive medication screening, and substance-use assessments. The required presence of a peer treatment monitor adds a final layer of safety; if signs of overdose are ever observed, they are instructed to call 911 immediately.
Is Ketamine Addictive?
Dependence on ketamine is primarily documented in patterns of chronic, unsupervised recreational use — not in time-limited therapeutic protocols. Ketamine is classified as a Schedule III controlled substance by the DEA, meaning it has accepted medical use and a lower abuse potential than Schedule I or II substances.7 Dependence typically manifests as tolerance, cravings, and withdrawal symptoms such as fatigue, anxiety, and nightmares.
This type of dependence is primarily documented in patterns of chronic, frequent, unsupervised recreational use. It is not commonly reported in defined therapeutic protocols that include structured prescribing, a finite treatment course, and ongoing clinical assessment.8
Clinician-supervised programs include strict safeguards to proactively minimize misuse risk. These include clinician-controlled prescribing, finite session counts, substance-use screening, and ongoing clinical assessment.
Tolerance and Cravings
Tolerance and cravings are the primary hallmarks of developing a substance dependence. Tolerance means your body adapts to the medication, requiring higher doses to achieve the original effect.
Tolerance develops more rapidly with frequent, high-dose use outside of medical supervision. In therapeutic settings, clinician-determined dosing and defined treatment courses are specifically designed to avoid this pattern of escalation.
If a client notices changes in their response to ketamine or feels a compulsive desire to use it, clinician consults are designed to assess and address these concerns immediately.
Risk Factors for Misuse
The primary risk factors for ketamine misuse include a personal or family history of substance use disorder, concurrent use of other substances, and unsupervised access to the medication.
These risk factors are well-documented in the addiction medicine literature and apply broadly across many controlled substances, not just ketamine.9
Clinical intake screening specifically evaluates your substance-use history as a core part of the eligibility assessment. This ensures that treatment is only prescribed when medically appropriate.
Clinical Safeguards That Reduce Misuse Risk
Responsible ketamine therapy relies on protocol-driven safeguards, including clinician-controlled prescribing, finite session counts, substance-use screening, and ongoing clinical monitoring.
These elements function as an integrated safety system. Clinicians determine exact dosing, sessions are part of a defined program rather than open-ended refills, and follow-up consults assess your ongoing response.
These safeguards are part of responsible care design. They are built into the protocol from the outset to protect patient health.
Does Ketamine Therapy "Get You High"?
Ketamine at therapeutic doses produces an altered state of consciousness—including dissociation, perceptual shifts, and sometimes euphoria—that some people colloquially describe as a "high."
However, the therapeutic experience is intentionally induced at sub-anesthetic doses within a clinical setting, paired with preparation and integration to channel the experience toward healing goals. This is pharmacologically and contextually different from recreational use, where the goal is simply the altered state itself.
The dissociative experience is understood by researchers as part of the therapeutic mechanism. It is associated with neuroplasticity and the capacity to shift entrenched thought patterns, rather than being a side effect to be minimized.10
Longer-Term Ketamine Side Effects With Frequent or Unmonitored Use
It is important to distinguish between the side effect profile of time-limited, clinician-supervised therapeutic use and the risks documented with chronic, frequent, or unsupervised use patterns. The key long-term risk categories include bladder and urinary tract damage, cognitive and memory changes, mood disturbances, and liver function changes.
The clinical literature regarding these long-term risks is drawn predominantly from studies of chronic recreational users, who often use ketamine daily or near-daily at high doses over months or years.11
Therapeutic programs use sub-anesthetic doses over defined treatment courses with clinical monitoring, representing a fundamentally different exposure pattern. However, any new or persistent symptoms should always be reported to your clinician promptly.
Bladder and Urinary Tract Symptoms
Ketamine cystitis—characterized by bladder pain, urgency, frequency, incontinence, and blood in the urine—is the most well-documented long-term organ effect.
Ketamine and its metabolites can directly irritate the urothelial lining of the bladder. This damage is dose- and duration-dependent, primarily reported in individuals using ketamine frequently at high doses over extended periods.12
In therapeutic protocols, cumulative exposure is substantially lower. Any new urinary symptoms should be reported to your clinician immediately so they can evaluate your treatment plan.
Memory and Concentration Changes
Cognitive effects, particularly deficits in working memory, episodic memory, and attention, have been documented in chronic recreational ketamine users.
Neuropsychological studies of frequent recreational users show measurable cognitive impairment, particularly in memory domains.13 The relationship between therapeutic-dose exposure and long-term cognition is less well-characterized but remains an active area of clinical research.
Clinician consults across your treatment course include an assessment of your cognitive function and overall response to ensure the therapy remains beneficial.
Mood Changes and Flashbacks
Mood disturbances, including depressive episodes, anxiety, and flashbacks, have been reported in some chronic recreational users.
These issues are more commonly associated with heavy recreational use and may reflect both direct pharmacological effects and the psychological consequences of substance misuse. In therapeutic contexts, your mood is actively monitored as a core part of the treatment protocol.
Clinicians assess your psychological response at each consult. Worsening mood or new psychiatric symptoms are grounds for immediate treatment plan adjustment.
Liver Function Changes
Hepatotoxicity and biliary changes, such as cholestatic liver injury, are documented risks in chronic, high-dose ketamine users.
Ketamine is metabolized hepatically, meaning it is processed by the liver. Prolonged high-dose exposure can stress liver function, and elevated liver enzymes have been reported in case series of heavy recreational users.14
Therapeutic protocols involve substantially lower cumulative exposure, reducing this risk. Clinicians may order liver function tests if your medical history indicates it is clinically necessary.
Ketamine Interactions and Substances to Avoid
Drug interactions are a critical safety consideration in ketamine therapy. Because ketamine affects the central nervous system, combining it with other CNS-active substances can dangerously amplify risks.
The highest-risk combinations involve substances that cause sedation or respiratory depression. Clinical intake includes a full medication review to identify these risks before treatment begins.
You must disclose all medications, supplements, and substances to your clinician—including alcohol and cannabis use—and never adjust prescribed medications without clinical guidance.
- Alcohol: A CNS depressant that significantly increases the risk of respiratory depression, excessive sedation, and severely impaired coordination when combined with ketamine.
- Benzodiazepines: Medications like alprazolam or diazepam that compound ketamine's sedative effects and can increase the risk of respiratory depression.
- Opioids: Pain medications that, when combined with ketamine, significantly increase the risk of life-threatening respiratory depression and overdose.
- Sleep Medications: Sedative-hypnotics like zolpidem that can potentiate ketamine's effects, leading to unsafe levels of sedation.
How Ketamine Is Administered and How Route Affects Side Effects
Ketamine can be administered through several routes, and the chosen method affects the medication's bioavailability, onset time, intensity, and specific side effect profile. The primary routes are intravenous (IV), intramuscular (IM), sublingual (tablets), subcutaneous (injectables), and intranasal (Spravato/esketamine).
Ketamine has been FDA-approved as an anesthetic since 1970 and has been on the WHO List of Essential Medicines since 1985.15Off-label prescribing for psychiatric indications is a widespread, legally accepted medical practice, with research suggesting approximately 21% of all psychiatric prescriptions are written off-label.16
Spravato (esketamine) received FDA approval for treatment-resistant depression in 2019 under a REMS program requiring mandatory in-clinic administration and monitoring.17 The FDA issued a 2023 safety communication noting that compounded ketamine products are not FDA-approved and may pose risks including sedation, dissociation, blood pressure increases, respiratory complications, misuse, and urinary symptoms, even though compounding pharmacies are a regulated part of U.S. healthcare.18
The appropriate route depends on your clinical needs, individual response, and treatment goals. No single route is inherently superior; each involves different tradeoffs regarding comfort, cost, and monitoring requirements.
How Clinician-Supervised Protocols Reduce Ketamine Side Effect Risk
The safety of ketamine therapy is a function of clinical supervision, thorough screening, and defined treatment frameworks—not dose size alone.1 Responsible ketamine therapy programs build safety into every single stage of the treatment process.
These protocols ensure that patients are medically appropriate for treatment, properly prepared for the experience, and supported throughout their care. This clinical framework is what separates therapeutic use from the risks associated with recreational use.
Building on decades of clinical research on ketamine's therapeutic applications, Mindbloom has published two of the largest peer-reviewed, real-world outcomes studies of at-home ketamine therapy to date. Mindbloom is also one of the only at-home ketamine providers offering subcutaneous administration in addition to sublingual tablets.
Medical Screening and Eligibility
Eligibility is determined through a comprehensive clinical assessment process, not binary rules. Clinicians evaluate your medical history, psychiatric history, current medications, substance use, and cardiovascular health.
Ketamine therapy may not be appropriate for individuals with certain contraindications, such as uncontrolled hypertension or active psychosis. The clinician makes this determination during screening to ensure your safety.
Clinician Oversight and Personalized Treatment Frequency
Treatment frequency is personalized based on your individual needs and clinical guidance, rather than a fixed interval. Clinician consults occur at defined points throughout the program to assess your response, adjust dosing, and monitor for any emerging concerns.
Dosing is always sub-anesthetic and strictly clinician-determined. This ongoing oversight allows for timely adjustments if side effects become bothersome.
At-Home Session Preparation and Support
The session protocol includes detailed preparation materials, set-and-setting guidance, and a required peer treatment monitor.
Clients also receive a Bloombox containing session essentials like a blood pressure monitor and journal to ensure a safe environment.
Integration Support and Follow-Up
Integration is a core component of the program, not optional aftercare. Guide coaching sessions, unlimited Group Integration Circles, unlimited guide messaging, and app-based programs support durable outcomes.
These integration practices help sustain progress over time and provide a space to process any challenging emotions that arise.
Mindbloom Safety Findings From Peer-Reviewed Outcomes Studies
Mindbloom's clinical model has been evaluated in published research. In a peer-reviewed study of 11,441 patients conducted using the Mindbloom clinical protocol, side effects occurred in approximately 4–5% of sessions.19
In the Mindbloom outcomes study, serious adverse events occurred in fewer than 0.1% of sessions, and the discontinuation rate due to adverse events was 0.4%.20 Individual results may vary.
These findings build on decades of ketamine research, demonstrating a favorable safety profile when administered within a clinically managed framework.
Disclaimer / Safety Information
IMPORTANT SAFETY INFORMATION
Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary.Full safety information: www.mindbloom.com/safety-information
OFF-LABEL USE DISCLOSURE
Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.
Frequently asked questions
How Long Do Ketamine Side Effects Last?
If they do occur, the most common side effects, such as dissociation, nausea, dizziness, and fatigue, typically resolve within a few hours of the session ending. Driving and operating machinery should be avoided until after a full night of sleep.
How Long Does Nausea Last After Ketamine?
Nausea typically subsides within a few hours and often diminishes naturally with subsequent sessions. Your clinician may recommend fasting guidelines or prescribe anti-nausea medication as part of your protocol to manage this.
What Is Ketamine Used For?
Ketamine has been FDA-approved as an anesthetic since 1970 and is prescribed off-label for <a href="https://www.mindbloom.com/blog/ketamine-for-depression-effective-treatment-therapy">depression</a>, anxiety, <a href="https://www.mindbloom.com/blog/everything-you-need-to-know-about-ketamine-for-ptsd">PTSD</a>, and related conditions. A substantial body of peer-reviewed research supports its therapeutic applications across multiple mental health contexts, including OCD, chronic pain, and grief.<sup>21</sup>
What Should I Do if I Feel Panicky During an At-Home Session?
Preparation materials include specific breathing techniques and grounding exercises for this situation, and your peer treatment monitor is present throughout the session to provide support. If panic persists or feels unmanageable, you should contact your clinician or Mindbloom's 24/7 support team.
Can I Take Ketamine With Antidepressants or ADHD Medication?
Many people safely continue their current psychiatric medications during ketamine therapy, but all medications must be disclosed to your clinician during intake. They will evaluate potential interactions and adjust your protocol if needed; never stop or adjust any medication without clinical guidance.
Is Ketamine Dangerous?
When used recreationally at high doses or combined with central nervous system depressants, ketamine carries significant risks including overdose and respiratory depression. However, within a clinician-supervised therapeutic protocol that includes medical screening, medication review, and <a href="https://www.mindbloom.com/safety">session safety requirements</a>, serious adverse events are rare.
Can Ketamine Cause Anxiety?
While ketamine is used to treat anxiety disorders, the altered state of consciousness during a session can temporarily amplify pre-existing anxiety or cause brief agitation in some individuals. This in-session anxiety is usually transient and is managed through preparation, breathing techniques, and the presence of a peer treatment monitor.
Mindbloom Treatment
See what might be possible with clinician-guided, at-home ketamine therapy. New client programs start at $165 per session.
Authors
